Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Use this PSTV page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PSTV quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PSTV SEC filings page. Lician reads the product cache first so this HTML stays unique to Plus Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full PSTV income, balance, and cash tables.